JP2006515886A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515886A5 JP2006515886A5 JP2006501021A JP2006501021A JP2006515886A5 JP 2006515886 A5 JP2006515886 A5 JP 2006515886A5 JP 2006501021 A JP2006501021 A JP 2006501021A JP 2006501021 A JP2006501021 A JP 2006501021A JP 2006515886 A5 JP2006515886 A5 JP 2006515886A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- hydrogen
- alkoxy
- propyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44087303P | 2003-01-17 | 2003-01-17 | |
| US44391103P | 2003-01-30 | 2003-01-30 | |
| PCT/US2004/001279 WO2004064741A2 (en) | 2003-01-17 | 2004-01-20 | Compounds, compositions, and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006515886A JP2006515886A (ja) | 2006-06-08 |
| JP2006515886A5 true JP2006515886A5 (cg-RX-API-DMAC7.html) | 2006-10-19 |
Family
ID=32776034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501021A Pending JP2006515886A (ja) | 2003-01-17 | 2004-01-20 | 化合物、組成物、および方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20070149500A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1594849A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006515886A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004064741A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| US6794379B2 (en) | 2001-06-06 | 2004-09-21 | Tularik Inc. | CXCR3 antagonists |
| US7009049B2 (en) | 2002-02-15 | 2006-03-07 | Cytokinetics, Inc. | Syntheses of quinazolinones |
| US7166595B2 (en) | 2002-05-09 | 2007-01-23 | Cytokinetics, Inc. | Compounds, methods and compositions |
| AU2003270015A1 (en) | 2002-05-09 | 2003-12-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| WO2003103575A2 (en) | 2002-05-23 | 2003-12-18 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| CA2489367A1 (en) | 2002-06-14 | 2003-12-24 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| WO2004009036A2 (en) | 2002-07-23 | 2004-01-29 | Cytokinetics, Inc. | Compounds compositions and methods |
| WO2004034972A2 (en) | 2002-09-30 | 2004-04-29 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| ES2339862T3 (es) * | 2003-06-20 | 2010-05-26 | Novartis Vaccines And Diagnostics, Inc. | Compuestos de piridino 1,2-a-pirimidin-4-ona como agentes anticancerosos. |
| JP2007510652A (ja) * | 2003-11-03 | 2007-04-26 | サイトキネティクス・インコーポレーテッド | ピリミジン−4−オン化合物、組成物、および方法 |
| EP1692112A4 (en) | 2003-12-08 | 2008-09-24 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS, AND METHODS |
| ATE419249T1 (de) * | 2004-04-06 | 2009-01-15 | Novartis Vaccines & Diagnostic | Inhibitoren von mitotischem kinesin |
| US20070287703A1 (en) * | 2004-07-22 | 2007-12-13 | Astrazeneca Ab | Fused Pyrimidones Useful in the Treatment and the Prevention of Cancer |
| CN101027309B (zh) | 2004-08-18 | 2010-10-27 | 阿斯利康(瑞典)有限公司 | 所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途 |
| JP4545196B2 (ja) * | 2005-01-19 | 2010-09-15 | メルク・シャープ・エンド・ドーム・コーポレイション | 有糸分裂キネシン阻害剤 |
| EP1855685A4 (en) * | 2005-01-19 | 2009-12-23 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINE |
| DE602006015658D1 (de) | 2005-06-27 | 2010-09-02 | Amgen Inc | Entzündungshemmende arylnitrilverbindungen |
| EP1942888A2 (en) * | 2005-11-02 | 2008-07-16 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| GEP20125415B (en) | 2007-01-05 | 2012-03-12 | Novartis Ag | Imidazole derivatives as kinesin spindle protein inhibitors (eg-5) |
| CN118027024A (zh) * | 2022-11-14 | 2024-05-14 | 南京同诺康医药科技有限公司 | 吡啶并[1,2-a]嘧啶-4-酮衍生物及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3609598A1 (de) * | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
| CA2465491A1 (en) * | 2001-11-07 | 2003-05-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| WO2003103575A2 (en) * | 2002-05-23 | 2003-12-18 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| WO2004009036A2 (en) * | 2002-07-23 | 2004-01-29 | Cytokinetics, Inc. | Compounds compositions and methods |
| US20040024596A1 (en) * | 2002-07-31 | 2004-02-05 | Carney Laurel H. | Noise reduction system |
| EP1539180A4 (en) * | 2002-08-21 | 2006-08-30 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
-
2004
- 2004-01-20 JP JP2006501021A patent/JP2006515886A/ja active Pending
- 2004-01-20 US US10/541,441 patent/US20070149500A1/en not_active Abandoned
- 2004-01-20 EP EP04703589A patent/EP1594849A4/en not_active Withdrawn
- 2004-01-20 WO PCT/US2004/001279 patent/WO2004064741A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005523312A5 (cg-RX-API-DMAC7.html) | ||
| RU2004133325A (ru) | Соединения, композиции на их основе и способы их использования | |
| EP2545057B1 (en) | Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd | |
| CA2413426A1 (en) | Methods and compositions utilizing quinazolinones | |
| CN100491358C (zh) | 嘧啶酮类化合物、组合物及方法 | |
| CN103649093B (zh) | 取代的咪唑并吡啶和咪唑并哒嗪及其用途 | |
| AU679608B2 (en) | Imidazodiazepines | |
| RU2002103201A (ru) | ИНГИБИТОРЫ Th2 -дифференцировки | |
| CA2747326C (en) | Combination of aurora kinase inhibitors and anti-cd20 antibodies | |
| CA2866213A1 (en) | Substituted azabicycles and use thereof | |
| AU2003300255A1 (en) | Substituted pyrrolo-pyrazole derivatives as kinase inhibitors | |
| CA2792725A1 (en) | Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd | |
| NZ515501A (en) | Use of pyrazolo[4,3-d]pyrimidin-7-ones, pyrazolo[3,4-d]pyrimidin-4-ones, quinazolin-4-ones, purin-6-ones, pyrido[3,2-d]pyrimidin-4-ones and tetracyclic derivatives to treat nitrate-induced tolerance | |
| EP1996550A2 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
| ZA200210277B (en) | Melanocortin receptor ligands. | |
| KR20230010729A (ko) | 단독 요법 및 병용 요법 | |
| US7705049B2 (en) | Methods for treating non-melanoma cancers with PABA | |
| JP2021518379A5 (cg-RX-API-DMAC7.html) | ||
| CN102665700A (zh) | 治疗实体瘤和其它恶性肿瘤的方法和组合物 | |
| EP2036909A1 (en) | Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof | |
| RU2005114491A (ru) | Соединения, составы и способы их использования | |
| JP2006515886A (ja) | 化合物、組成物、および方法 | |
| JP2006502219A5 (cg-RX-API-DMAC7.html) | ||
| US20220079952A1 (en) | Uses of Radiation and Benzodiazepine Derivatives in Cancer Therapies | |
| Hafez et al. | Design, synthesis and pharmacological evaluation of new nonsteroidal anti-inflammatory derived from 3-aminobenzothieno [2, 3-d] pyrimidines |